Small caps could be ready to go big

Small-cap stocks are making a notable resurgence, with the Russell 2000 seeing consistent gains and outperforming the S&P 500 in recent months. This shift comes amid expectations of rate cuts by the Federal Reserve, which traditionally favor smaller companies due to their reliance on floating-rate debt. Additionally, policy changes like tax relief and deregulation could further enhance earnings for small caps by reducing compliance costs and offering improved tax deductions.

Biotech firms stand to benefit from lower rates as they often rely on external financing, while the IPO market shows promise with a robust lineup expected this September. Advances in AI are also poised to aid small businesses by democratizing computing power and potentially reducing operational costs, especially in sectors like healthcare where substantial savings are anticipated long-term.

As market dynamics evolve beyond dominance by megacap tech giants, there's growing potential for diversification benefits through strategic stock selection among innovative smaller companies that can capitalize on these emerging trends.